Zobeiri M .2011 .Prophylaxis for deep venous thrombosis: knowledge and practice of surgeons. Pak J Med Sci, 27 : 16-20.
Ahmed A .2005 .Prevention of deep vein thrombosis and pulmonary embolism in the perioperative period: A review. J Pak Med Assoc, 55(8) : 343-7.
Akhtar N,Deleu D,Kamran S. .2006 .Hematologic disorders and Cerebral venous thrombosis. J Pak Med Assoc, 56(11) : 498-500.
Barsam SJ,Patel R,Arya R .2013 .Anticoagulation for prevention and treatment of cancer-related venous thromboembolism. Br J Haematol, : .
Naz R,Naz S,Mehboob M,Khalid GH .2005 .Comparison of unfractionated heparin vs low molecular weight heparin in the treatment of acute deep vein thrombosis. J Coll Physicians Surg Pak Oct, 15(10) : 601-4.
Verso M,Agnelli G,Ageno W,Imberti D,Moia M,Palareti G .2012 .for the MASTER investigators. Long-term death and recurrence in patients with acute venous thromboembolism: The MASTER registry. Thromb Res, : .
.2004 .Serum lipids and lipoproteins in patients with documented Coronary Artery Disease. Pak J Pharm Sci Jul, 17(2) : 85-92.
Anderson FA,Spencer FA .2003 .107: I-9. Circulation, : .
Michota FA .2006 .Preventing venous thromboembolism in surgical patients. Cleve Clin J Med, 73(suppl 1) : 88s-94.
Attaya H,Wysokinski WE,Bower T,Litin S,Daniels PR,Slusser J,Heit JA,McBane RD .2013 .Three-month cumulative incidence of thromboembolism and bleeding after periprocedural anticoagulation management of arterial vascular bypass patients. J Thromb Thrombolysis, 35(1) : 100-6.
Zurawska U,Parasuraman S,Goldhaber SZ .2007 .Prevention of pulmonary embolism in general surgery patients. Circulation, 115 : 302-7.
.2013 .Prevalence of variants that confer risk for venous thromboembolism in an elderly population of North Eastern Brazil. Genet Mol Res, 12 : .
Harish J,Warkentin TE,Shaughnessy SG,Anand SS,Halperin JL,Raschke R .2001 .Heparin and low molecular weight heparin; mechanism of action, pharmacokinetics, dosing, monitoring, efficacy and safety. Chest, 119 : 64-94.
Eley KA,Parker RJ,Watt-Smith SR .2013 .Low molecular weight heparin in patients undergoing free tissue transfer following head and neck ablative surgery: review of efficacy and associated complications. Br J Oral Maxillofac Surg, : S0266-356.
Mirza W,Ashraf S,Fawad A .2005 .Physical versus combined physical and pharmacological prophylaxis against Deep Vein Thrombosis in patients undergoing major surgery. J Rawal Med Coll, 9(1) : 12-7.
Raskob G,Büller H,Prins M,Segers A,Shi M,Schwocho L .2013 .Edoxaban for the long-term treatment of venous thromboembolism: rationale and design of the Hokusai-VTE study. J Thromb Haemost, : 10.
JI Weitz .1997 .Low-molecular-weight heparins. N Engl J Med, 337 : 688-99.
.2001 .Prevention of venous thromboembolism. Chest, 119 : 132-75.
Praxis .2007 .. , 96(18) : 733-7.
.2011 .Bauer KA. Long-term management of venous thromboembolism: a 61-year-old woman with unprovoked venous thromboembolism. JAMA, 305(13) : 1336-45.
Prandoni P,Dalla Valle F,Piovella C,Tormene D,Pesavento R,Galanaud JP,Sevestre MA,Genty C .2014 .Incidence and predictors of venous thromboembolism recurrence after a first isolated distal deep vein thrombosis. J Thromb Haemost, 12(2) : 436-43.
.2012 .Comparison of bleeding complications and 3-year survival with low-molecularweight heparin versus unfractionated heparin for acute myocardial infarction: The FAST-MI registry. Arch Cardiovasc Dis, 105 : 347-54.